药物发现的新方法 872条(本栏目收费,不能显示细节,电话15274084725)
‘Non-Lipinski’ drugs, 44, 45 45
Caenorhabditis elegans, 63–64 64
Nonribosomal peptide synthases (NRPS),105, 106 106
Non-small cell lung cancer (NSCLC) model, 213 213
Novel oral anticoagulants (NOACs), 230, 231 231
NRPS. See Nonribosomal peptide synthases (NRPS) NS309, 133, 134 134
Off-target effects (OTEs), 34–36 36
Oncotype DX® test, 291 291
Optimally implement robust, 173–175 175
OTEs. See Off-target effects (OTEs) 0
PAEC. See PGR modulator-associated 0
endometrial change (PAEC) 0
Papaver somniferum, 92 92
Pathogenic microorganisms, 103–104 104
Patient-derived xenograft (PDX) models 0
colorectal cancer, 213 213
pancreatic cancer, 213–214 214
preclinical strategies, component, 216 216